Michael E. Laurila

发表

Small-Volume Continuous Manufacturing of Merestinib. Part 1. Process Development and Demonstration

Martin D. Johnson, John R. Howell, Moussa Boukerche, 2019, Organic Process Research & Development.

Synthesis of BACE Inhibitor LY2886721. Part II. Isoxazolidines as Precursors to Chiral Aminothiazines, Selective Peptide Coupling, and a Controlled Reactive Crystallization

Michael E. Laurila, A. L. Frederick, Derek R. Starkey, 2015 .

α-Aminoamides as ligands in Goldberg amidations

Michael E. Laurila, Aurpon W. Mitra, J. R. Martinelli, 2013 .

An automated repeating batch with catalyst recycle approach to nitro group hydrogenolysis

Martin D. Johnson, Michael E. Laurila, James R. Stout, 2017 .

An Asymmetric Synthesis of a Chiral Sulfone Acid with Concomitant Hydrolysis and Oxidation to Enable the Preparation of a Glucokinase Activator

J. J. Petkus, Michael E. Laurila, J. Wepsiec, 2012 .

Process Development for a Key Synthetic Intermediate of LY2140023, a Clinical Candidate for the Treatment of Schizophrenia

Michael E. Laurila, Cheryl A. Bye, K. A. Sullivan, 2011 .

Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists

Michael E. Laurila, L. L. Winneroski, G. Etgen, 2007 .

Optimized Catalytic Enantioselective Aryl Transfer Process Gives Access to mGlu2 Receptor Potentiators

Michael E. Laurila, Bruce W. Shaw, Michael A. Staszak, 2007 .

Selective Monoarylation of Benzenediols via Dianion Intermediates

Michael E. Laurila, K. A. Sullivan, C. Xie, 2007 .

The Development of Practical Synthetic Routes to a CB2 Agonist: Efficient Construction of a Densely Substituted Purine Core

Michael E. Laurila, Michael A. Staszak, M. Staszak, 2013 .